Investing.com - Financial Markets Worldwide

Syngen Biotech Co Ltd (8279)

TPEX
Currency in TWD
121.00
-3.00(-2.42%)
Closed·
8279 Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
High dividend Yield
8279 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
121.00124.00
52 wk Range
100.00148.00
Key Statistics
Edit
Bid/Ask
106.50 / 107.00
Prev. Close
128
Open
124
Day's Range
121-124
52 wk Range
100-148
Volume
79.88K
Average Volume (3m)
56.24K
1-Year Change
-11.36%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
8279 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 10
High shareholder yield
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Syngen Biotech Co Ltd Company Profile

Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies; science-based and bio active pharmaceutical ingredients under the Oraltics, IMMUPHYLA, V3, ST4SanTex, GUARDSPO, benefiGANO, EXPUNERGY, and BIOJOVIAL brands; and private labelling services. It also provides organic food OEM/ODM, explosion proof extraction, brand agency, and wholesale distribution services. The company serves the sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox industries. It exports to approximately 20 countries. Syngen Biotech Co.,Ltd. was founded in 1988 and is based in Tainan City, Taiwan.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
247
Market
Taiwan

Compare 8279 to Peers and Sector

Metrics to compare
8279
Peers
Sector
Relationship
P/E Ratio
11.7x−17.1x−0.5x
PEG Ratio
0.660.130.00
Price/Book
1.5x2.6x2.6x
Price / LTM Sales
1.5x6.4x3.2x
Upside (Analyst Target)
-0.0%38.8%
Fair Value Upside
Unlock−8.1%5.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 10.31%
Dividend Yield
4.13%
Industry Median 2.62%
Annualised payout
5.00
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
Aug 29, 2025
EPS / Forecast
3.23 / --
Revenue / Forecast
607.58M / --
EPS Revisions
a
a
Unlock
Last 90 days

8279 Income Statement

FAQ

What Stock Exchange Does Syngen Biotech Trade On?

Syngen Biotech is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for Syngen Biotech?

The stock symbol for Syngen Biotech is "8279."

What Is the Syngen Biotech Market Cap?

As of today, Syngen Biotech market cap is 3.28B.

What Is Syngen Biotech's Earnings Per Share (TTM)?

The Syngen Biotech EPS (TTM) is 10.31.

When Is the Next Syngen Biotech Earnings Date?

Syngen Biotech will release its next earnings report on 12 Nov 2025.

From a Technical Analysis Perspective, Is 8279 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Syngen Biotech Stock Split?

Syngen Biotech has split 3 times.

How Many Employees Does Syngen Biotech Have?

Syngen Biotech has 247 employees.

What is the current trading status of Syngen Biotech (8279)?

As of 31 Aug 2025, Syngen Biotech (8279) is trading at a price of 121.00, with a previous close of 128.00. The stock has fluctuated within a day range of 121.00 to 124.00, while its 52-week range spans from 100.00 to 148.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.